Document:

Exhibit 10.5

 

___________, 2020

 

LifeSci Acquisition II Corp.

250 W. 55th Street, #3401

New York, NY 10019

 

Ladies and Gentlemen:

 

LifeSci Acquisition
II Corp. (the “Company”), a blank check company formed for the purpose of acquiring one or more businesses or entities
(a “Business Combination”), intends to register its securities under the Securities Act of 1933, as amended (“Securities
Act”), in connection with its initial public offering (“IPO”), pursuant to a registration statement on Form S-1
(“Registration Statement”).

 

The undersigned
hereby commits that it will purchase an aggregate of 3,033,333 warrants (or up to 3,283,333 warrants if the over-allotment
option is exercised in full) of the Company (“Private Warrants”), at a price of $0.90 per warrant in the form
attached hereto as Exhibit A for an aggregate purchase price of $2,730,000 (the “Private Warrant Purchase
Price”).

 

At least twenty-four
(24) hours prior to the effective date of the Registration Statement, the undersigned will cause the Private Warrant Purchase Price
to be delivered to Loeb & Loeb, LLP (“Loeb”), as escrow agent, by wire transfer as set forth in the instructions
attached as Exhibit B to hold in a non-interest bearing account until the Company consummates the IPO.

 

The consummation of
the purchase and issuance of the Private Warrants shall occur simultaneously with the consummation of the IPO. Simultaneously with
the consummation of the IPO, Continental shall deposit the Private Warrant Purchase Price, without interest or deduction, into
the trust fund (“Trust Fund”) established by the Company for the benefit of the Company’s public stockholders
as described in the Registration Statement.

 

Each of the Company
and the undersigned acknowledges and agrees that Loeb is serving hereunder solely as a convenience to the parties to facilitate
the purchase of the Private Warrants.

 

Additionally, the undersigned
agrees:

 

		·	not to propose, or vote in favor of, an amendment to the Company’s Amended and Restated Certificate
of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of the Company’s
shares of Common Stock sold in the IPO if the Company does not complete an initial Business Combination within 24 months from the
closing of the IPO, unless the Company provides the holders of shares of Common Stock sold in the IPO with the opportunity to redeem
their shares of Common Stock upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate
amount of the Trust Fund, including interest earned on Trust Fund and not previously released to the Company to pay the Company’s
franchise and income taxes, divided by the number of then outstanding shares of Common Stock sold in the IPO;

 

		·	the undersigned will not participate in any liquidation distribution with respect to the Private
Warrants (but will participate in liquidation distributions with respect to any shares of Common Stock purchased
by the undersigned in the IPO or in the open market) if the Company fails to consummate a Business Combination;

 

     

     

    

 

		·	that the Private Warrants and underlying securities will not be transferable until after the consummation
of a Business Combination except (i) to the Company’s pre-IPO stockholders, or to the Company’s officers, directors,
advisors and employees, (ii) transfers to the undersigned’s affiliates or its members upon its liquidation, (iii) to relatives
and trusts for estate planning purposes, (iv) by virtue of the laws of descent and distribution upon death, (v) pursuant to a qualified
domestic relations order, (vi) by private sales at prices no greater than the price at which the Private Warrants were originally
purchased or (vii) to the Company for cancellation in connection with the consummation of a Business Combination, in each case
(except for clause vii) where the transferee agrees to the terms of the transfer restrictions; and

 

		·	the Private Warrants will include any additional terms or restrictions as is customary in other
similarly structured blank check company offerings or as may be reasonably required by the underwriters in the IPO in order to
consummate the IPO, each of which will be set forth in the Registration Statement.

 

The undersigned acknowledges
and agrees that the purchaser of the Private Warrants will execute agreements in form and substance typical for transactions of
this nature necessary to effectuate the foregoing agreements and obligations prior to the consummation of the IPO as are reasonably
acceptable to the undersigned, including but not limited to an insider letter.

 

The undersigned hereby
represents and warrants that:

 

(a)           
it has been advised that the Private Warrants have not been registered under the Securities Act;

 

(b)           
it will be acquiring the Private Warrants for its account for investment purposes only;

 

(c)           
it has no present intention of selling or otherwise disposing of the Private Warrants in violation of the securities
laws of the United States;

 

(d)           
it is an “accredited investor” as defined by Rule 501 of Regulation D promulgated under the Securities
Act of 1933, as amended;

 

(e)           
it has had both the opportunity to ask questions and receive answers from the officers and directors of the Company
and all persons acting on its behalf concerning the terms and conditions of the offer made hereunder;

 

(f)            
it is familiar with the proposed business, management, financial condition and affairs of the Company;

 

    2

     

    

 

(g)           it has full power, authority and legal capacity to execute and deliver this letter and any documents contemplated
herein or needed to consummate the transactions contemplated in this letter; and

 

(h)            this letter constitutes its legal, valid and binding obligation, and is enforceable against it.

 

This letter agreement
constitutes the entire agreement between the undersigned and the Company with respect to the purchase of the Private Warrants,
and supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral,
with respect to the same.

 

	 	Very truly yours,
	 	 
	 	LIFESCI HOLDINGS LLC
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

	Accepted and Agreed:	 
	 	 
	LIFESCI ACQUISITION II CORP.	 
	 	 
	By:	 	 
	 	Name:	Andrew McDonald	 
	 	Title:	Chief Executive Officer	 

 

    3

     

    

 

Exhibit A

 

Form of Warrant

 

     

     

    

 

Exhibit B

 

Wire InstructionsExhibit 10.6

 

LIFESCI ACQUISITION II CORP.

250 W. 55th St., #3401

New York, NY 10019

 

_____, 2020

 

LifeSci Capital LLC

250 W. 55th St., #3401

New York, NY 10019

 

Ladies and Gentlemen:

 

This letter will confirm
our agreement that, commencing on the effective date (the “Effective Date”) of the registration statement
(the “Registration Statement”) for the initial public offering (the “IPO”)
of the securities of LifeSci Acquisition Corp. (the “Company”) and continuing until the earlier of (i)
the consummation by the Company of an initial business combination or (ii) the Company’s liquidation (in each case as described
in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”),
LifeSci Capital LLC (“LC”) shall make available to the Company certain office space, secretarial and
administrative services as may be required by the Company from time to time, situated at 250 W. 55th St., #3401, New York, NY 10019
(or any successor location). In exchange therefore, the Company shall pay LC a sum of $10,000 per month, respectively, on the Effective
Date and continuing monthly thereafter until the Termination Date. LC hereby agrees that it does not have any right, title, interest
or claim of any kind in or to any monies that may be set aside in a trust account (the “Trust Account”)
that may be established by the Company for the benefit of the Company’s public stockholders upon the consummation of the
IPO as described in the Registration Statement ( “Claim”) and hereby waives any Claim it may have in
the future as a result of, or arising out of, any negotiations, contracts or agreements with the Company and will not seek recourse
against the Trust Account for any reason whatsoever.

 

	 	Very truly yours,
	 	 
	 	LIFESCI ACQUISITION II
    CORP.
	 	 
	 	By:	                              
	 	Name: Andrew McDonald
	 	Title: Chief Executive Officer

 

	AGREED TO AND ACCEPTED BY:	 
	 	 
	LIFESCI
                                         CAPITAL LLC
	 
	 	 
	By:	                     	 
	Name: Andrew McDonald	 
	Title: Chief Executive OfficerSTOCK PURCHASE AGREEMENT

STOCK PURCHASE AGREEMENT

 

THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of the 17th day of November 2020, by and between Advanced Voice Recognition Systems, Inc., a Nevada corporation (“AVRS”) and the Purchaser.  Advanced Voice Recognition Systems, Inc. and the Purchaser are collectively referred to as the “Parties.”

In consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

1.Purchase and Sale of the Shares.   

a.Purchase and Sale.  Subject to the terms and conditions of this Agreement, the Purchaser agrees to purchase from AVRS, and AVRS agrees to sell to the Purchaser, 166,667 shares of the common stock of AVRS, referred to as the “Shares”.  This agreement does not apply to, and no referral fee shall be owed in connection with any proposed consultant agreements. 

b.Purchase Price.  The purchase price for the Shares is $.0120 per share, or $2,000.00. 

c.Payments.  The purchase price for the Shares will be paid on or before November 18, 2020: 

d.Certificates for the Shares.  Promptly after receipt of payment of the purchase price, AVRS shall instruct its transfer agent to prepare a stock certificate for 166,667 Shares for delivery to the Purchaser at the Purchaser’s address set forth on the signature page to this Agreement.  Each certificate shall have a legend substantially as follows:  THE OFFERED SHARES ARE RESTRICTED SECURITIES PURSUANT TO THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND SUBJECT TO CERTAIN IMPORTANT LIMITATIONS ON THEIR RESALE OR OTHER TRANSFER.  THESE SHARES MAY NOT BE RESOLD OR TRANSFERRED UNLESS THE SHARES ARE REGISTERED PURSUANT TO THE ACT AND QUALIFIED PURSUANT TO THE APPLICABLE STATE STATUTES, UNLESS AN EXEMPTION FROM SUCH REGISTRATION AND QUALIFICATION IS DEMONSTRATED TO THE SATISFACTION OF THE COMPANY. 

2.Representations and Warranties of AVRS.  AVRS represents and warrants to the Purchaser as follows: 

a.Due Incorporation and Good Standing.  AVRS is a corporation duly organized, validly existing and in good standing under the laws of the state of Nevada.   

b.Due Authorization.  All corporate action on the part of AVRS necessary for the authorization, execution and delivery of the Agreement and the performance of the obligations of AVRS hereunder, and the authorization, issuance, sale and delivery of the Shares has been taken, and this Agreement constitutes a valid and legally binding obligation of AVRS, enforceable in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting  

534390

enforcement of creditors’ rights generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

3.Representations and Warranties of the Purchaser.  The Purchaser represents and warrants to AVRS that: 

a.Due Authorization.   The Purchaser has the legal capacity and authority to enter into this Agreement.  All actions on the Purchaser’s part necessary for the authorization, execution and delivery of this Agreement and the performance of the obligations of the Purchaser hereunder in the purchase of the Shares has been taken, and this Agreement constitutes a valid and legal binding obligation of the Purchaser enforceable in accordance with its terms, except (i) as limited by applicable bankruptcy, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.    

b.Purchase Entirely for the Purchaser’s Own Account.  The Purchaser is purchasing the Shares in the ordinary course of business for investment purposes only for the Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the Shares.   

c.Information.  The Purchaser acknowledges review of reports filed by AVRS with the U.S. Securities and Exchange Commission, and that AVRS has provided the Purchaser with no indication of any value of the Shares or of AVRS.  There have been no representations, warranties or promises made to Purchaser by AVRS or any representative of AVRS that the Shares will appreciate in value, or that there will be any market for the resale of the Shares by the Purchaser.  The Purchaser understands that the Shares are extremely speculative and subject to a high degree of risk of loss of the Purchaser’s investment. The Purchaser and the Purchaser’s advisors, if any, have conducted their own investigation with respect to AVRS and the Shares, and have not relied upon any representation of AVRS in making the decision to invest in the Shares (other than those representations set forth in Section 2 of this Agreement).  The Purchaser has had an opportunity to discuss the terms and conditions of the investment in the Shares with management of AVRS and to obtain any additional information regarding the investment or AVRS that it has requested of management. 

d.Investment Experience.  The Purchaser is an investor in speculative securities with companies that have no revenue or profits and lack liquidity and capital resources and has such knowledge, sophistication and experience in business and financial matters as to be capable of evaluating the risks of the investment in the Shares.  The Purchaser confirms that he is able to bear the economic risk of an investment in the Shares and is able to afford a complete loss of such investment. 

e.Accredited Investor Status in the U.S. and Canada.  The Purchaser is an “accredited investor” as that term is defined in Regulation D promulgated under the U.S. Securities Act of 1933, as amended, as modified by Section 413(a) of the Dodd-Frank Act which deletes from the calculation of net worth the “value of the primary residence” of the investor.  The Purchaser is an “accredited investor” as that term is defined in Section 1.1 of the Canada National Instrument 45-106 (“NI45-106”).  Specifically, the Purchaser either has (1) net financial  

534390

assets in excess of Canadian $1,000,000; or (2) net income before taxes in excess of Canadian $200,000 per year in each of the most two recent calendar years or Canadian $300,000 combined with his spouse in each of the two most recent calendar years.

f.Restricted Securities.  The Purchaser understands that the Shares being purchased are characterized as “restricted securities” under the U.S. securities laws and that the Shares may be resold without registration only in certain limited circumstances, and that the Shares when issued to the Purchaser will bear the restricted legend restricting transfer.  The Purchaser is experienced in purchasing securities that are not readily transferable. 

4.Miscellaneous.   

a.Survival.  The warranties, representations and covenants of the Purchaser and AVRS contained in this Agreement shall survive the execution of this Agreement and the purchase and sale of the Shares. 

b.Counterparts.  This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature shall be considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original, and not a facsimile signature. 

c.Headings.  The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, the Agreement. 

534390

IN WITNESS WHEREOF, AVRS and the Purchaser have executed this Agreement as of the date first written above.

AVRS:

ADVANCED VOICE RECOGNITION SYSTEMS, INC.,
a Nevada corporation

By:
 Name:Walter Geldenhuys 

Title:President, CEO and CFO 

Address:

Advanced Voice Recognition Systems, Inc
7659 E. Wood Drive

Scottsdale, Arizona 85260

Facsimile:  (480) 626-5378

 

PURCHASER:

By:  

Name: 

Title:______________________________ 

Address:

534390

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]